G13.2 - Systemic atrophy primarily affecting the central nervous system in myxedema
- Applicable to Systemic atrophy primarily affecting the central nervous system in myxedema
- The 2025 edition of ICD10-CM G13.2 became effective on October 1, 2024.
- This is the American ICD10-CM version of G13.2 - other international versions of ICD10 G13.2 may differ.
- G13.2 is a Billable / Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
codefirst
- underlying disease, such as:
- hypothyroidism (E03.-)
- myxedematous congenital iodine deficiency (E00.1)
The following codes above G13.2 contain annotation back-references that may be applicable to G13.2:
Chapter: G00-G99 Diseases of the nervous system
Section: G10-G14 Systemic atrophies primarily affecting the central nervous system
Category: G13 Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere
Billable/Specific Code
Browse other similar CM codes
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd-10code.com